US equities
|
MU
$896.07
▼-0.98%
SPCX
$147.79
▼-0.11%
NVDA
$216.47
▼-0.29%
AAPL
$339.50
▼-1.00%
TSLA
$373.71
▲+1.54%
META
$694.25
▼-1.59%
AMZN
$262.63
▲+0.07%
SNDK
$1,365.38
▼-0.42%
MU
$896.07
▼-0.98%
SPCX
$147.79
▼-0.11%
NVDA
$216.47
▼-0.29%
AAPL
$339.50
▼-1.00%
TSLA
$373.71
▲+1.54%
META
$694.25
▼-1.59%
AMZN
$262.63
▲+0.07%
SNDK
$1,365.38
▼-0.42%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about AlloVir (ALVR)
Recent news which mentions AlloVir (ALVR)
Friday File: A Sale after 15 Years… and A Double-Down Buy After Six Months
April 05, 2024
Tags
Cyteir Therapeutics (CYTT)
Aligos Therapeutics (ALGS)
Precision BioSciences (DTIL)
From
Stock Gumshoe